Orkla Foods Sverige AB

2 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• NO ENGLISH1 refused line

  Required label information not in English

  Information that must appear on the label appeared not to be given in English, or not to be repeated in every language used on the label.

• NUTRIT LBL1 refused line

  Nutrition information missing from label

  The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.

• UNSAFE COL1 refused line

  Color additive unsafe under section 721

  The product appeared to be, or to contain, a color additive that is unsafe within the meaning of section 721(a) of the FD&C Act, the section that governs which color additives may be used and how.

Questions about Orkla Foods Sverige AB

Is Orkla Foods Sverige AB on an FDA import alert?

Yes. As of October 26, 2026, Orkla Foods Sverige AB is on the red list of FDA Import Alert 45-02, “Foods with illegal or undeclared colors”, for gron marsipan (marzipan green); FDA published the listing on September 29, 2026.

Has FDA refused shipments from Orkla Foods Sverige AB?

Yes. FDA refused 1 shipment line from Orkla Foods Sverige AB on September 1, 2026. The most recent, on September 1, 2026, was candy without chocolate n.e.c., charged as UNSAFE COL (color additive unsafe under section 721).

Why did FDA refuse Orkla Foods Sverige AB's shipments?

The most frequent charges are NO ENGLISH (required label information not in english, 1 line) and NUTRIT LBL (nutrition information missing from label, 1 line).

What is Orkla Foods Sverige AB's FEI number?

Orkla Foods Sverige AB's FDA Establishment Identifier (FEI) is 3012928284.

Can shipments from Orkla Foods Sverige AB still enter the U.S.?

Shipments of gron marsipan (marzipan green) from Orkla Foods Sverige AB can be detained without physical examination under Import Alert 45-02; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).